Latest News

Tuesday, February 20, 2018

Therapeutic Target for Glaucoma Could Have Treatment Ramifications for Alzheimer’s and Parkinson’s

A therapeutic target to preserve vision in glaucoma patients could have treatment ramifications for age-related neurodegenerative disorders like Alzheimer's and Parkinson's, according to findi…

Read the full story

Tuesday, February 20, 2018

Study: Central Corneal Thickness Could Affect Glaucoma Risk

Research led by Emory Eye Center scientist Eldon E. Geisert, PhD, shows that a protein that affects corneal thickness might also be connected to glaucoma risk. The study, conducted on mice, found t…

Read the full story

Tuesday, February 20, 2018

World-Renowned Speakers Featured During the 2018 ASCRS•ASOA Annual Meeting General Sessions

The ASCRS Opening General Session -- Saturday, April 14 -- will note the 2018 Honored Guest Awardees: R. Bruce Wallace, MD, and Richard Packard, MD, DO, FRCS, FRCOphth. Dr. Wallace is the founder …

Read the full story

Tuesday, February 20, 2018

Second Sight Announces Market Entry into Singapore with First Implant of Argus II Retinal Prosthesis System

Second Sight Medical Products announced market entry into Singapore, with the first patient implanted with the Company’s Argus II Retinal Prosthesis System. The implantation was facilitated by t…

Read the full story

Tuesday, February 20, 2018

GenSight Biologics Announces Publication of Positive Data from Phase 1/2 Trial of GS010 for Leber Hereditary Optic Neuropathy

GenSight Biologics announced publication of detailed results from the phase 1/2 clinical trial and long-term follow-up of GS010 in Leber Hereditary Optic Neuropathy (LHON) patients in Ophthalmology. T…

Read the full story

Monday, February 19, 2018

Novartis May Sell U.S. Generic Pill Business Amid Industry Struggles

The generic drug business has faced some struggles of recent amid that decline Swiss pharmaceutical company Novartis AG (NVS - Get Report) is reportedly gearing up to launch a sale process for its U.S…

Read the full story

Monday, February 19, 2018

Micropulse Laser an Option for Chronic Central Serous Chorioretinopathy

Functional and anatomical outcomes are similar after treatment with yellow micropulse (MP) laser or half-dose verteporfin photodynamic therapy (PDT) for chronic central serous chorioretinopathy (CSCR)…

Read the full story

Friday, February 16, 2018

A New Class of Drug to Treat Herpes Simplex Virus-1 Infection

Researchers at the University of Illinois at Chicago have now identified a small drug molecule that can clear the herpes simplex-1 virus (HSV-1) infection in the cells of the cornea. It works differen…

Read the full story

Friday, February 16, 2018

UK Biology Research May Lead to Treatment for Blinding Disorders, Including Glaucoma

Jakub Famulski, an assistant professor of biology in the University of Kentucky College of Arts and Sciences, has received a grant for over $1.8 million from the National Institutes of Health to …

Read the full story

Friday, February 16, 2018

Tobias Kippenberg and Jean-Pierre Wolf to Receive Zeiss Research Award

Prof. Tobias J. Kippenberg and Prof. Jean-Pierre Wolf are the 2018 winners of the prestigious Zeiss Research Award. The jury was impressed by their exceptional work. Tobias Kippenberg, Professor at…

Read the full story

Thursday, February 15, 2018

Anti-VEGF Agents Improve Vision Despite Ongoing Diabetic Macular Edema

In patients with diabetic macular edema (DME), aflibercept and ranibizumab are more effective than bevacizumab in preventing disease persistence, but each drug can lead to substantial gains in vision,…

Read the full story

Thursday, February 15, 2018

Biometry Can Be Conducted Soon After Removing Soft Contact Lenses

After patients remove their soft contact lenses, biometry can be performed sooner than currently advised, a study from Scotland suggests, according to a report in Reuters. "Contact lens use al…

Read the full story

Thursday, February 15, 2018

JDRF and The Mary Tyler Moore & S. Robert Levine, MD, Charitable Foundation Launch Research Moonshot to Restore Vision in People with Diabetes-Related Eye Disease

JDRF, an organization that funds type 1 diabetes (T1D) research, along with The Mary Tyler Moore & S. Robert Levine, MD, Charitable Foundation, are announcing a bold research effort to restore vis…

Read the full story

Wednesday, February 14, 2018

Ziemer USA Names Bret Fisher, MD, as Medical Monitor

Ziemer USA announced that Bret Fisher, MD, will serve as medical monitor to oversee the clinical performance of Ziemer medical devices, including the Ziemer Z8 femtosecond laser and the Galilei …

Read the full story

Wednesday, February 14, 2018

Long-Chain Lipids Could Help Prevent Dry Eye Disease, Suggest Study

Long-chain lipids in the most superficial layer of the tear film cause serious dry eye malady when they were abbreviated in mice -- an outcome that could help grow new medications for the illness, a…

Read the full story
Load More
 Stock Price  Change 
 ADVM $6.23  -2.73% 
 Aerie Pharmaceuticals, Inc. $54.15  -1.37% 
 Akorn, Inc. $31.63  -0.69% 
 Alimera Sciences, Inc. $1.26  -1.56% 
 Allergan $160.58  -2.11% 
 Applied Genetic Technologies $3.73  -0.67% 
 Bayer $30.39  -1.12% 
 Can-Fite Biopharma $1.90  -6.40% 
 Carl Zeiss Meditec $46.04  -7.52% 
 Clearside Biomedical $6.20  7.45% 
 Cooper Companies, Inc. $230.44  1.62% 
 Eleven Biotherapeutics $0.93  14.42% 
 Escalon Medical Corp. $0.29  52.63% 
 Essilor International $107.65  1.32% 
 Glaukos $31.28  7.64% 
 Imprimis Pharmaceuticals, Inc. $1.68  5.00% 
 IRIDEX Corporation $7.23  1.05% 
 Johnson & Johnson $130.85  -1.73% 
 Merck & Company, Inc. $55.01  -2.27% 
 NicOx $8.88  -0.56% 
 NovaBay Pharmaceuticals, Inc. $3.53  -1.06% 
 Novartis AG Common Stock $85.40  -1.74% 
 Ocular Therapeutix $4.81  -2.14% 
 Ophthotech Corporation $2.69  -5.94% 
 Quantel $6.40  -11.48% 
 Regeneron $323.01  -2.75% 
 Roche $29.77  2.73% 
 Second Sight Medical Products $1.61  -5.03% 
 Shire $126.74  -5.46% 
 Spark Therapeutics, Inc. $50.37  -7.58% 
 STAAR Surgical Company $15.15  0.00% 
 TearLab Corporation $0.31  -11.04% 
 Thrombogenics $4.16  0.97% 
 Valeant Pharmaceuticals $18.59  -1.56% 
 Xoma $25.82  -0.31%